CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH).

Hospitals turn to sports performance centers to offer athletes elite care — for the right price

FOXBOROUGH, Mass. — Jodi Cullity calls herself a pickleball fanatic. The 29-year-old is the founding CEO of Eleven-0, an organization devoted to the sport, in

March 22, 2024

Third Time’s a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise.

As an investigational diabetes drug implant that promises better adherence faces FDA review for a third time, safety concerns ranging from adverse heart and kidney

September 21, 2023

Healthy low-carb diet and time-restricted eating improve weight loss and gut health beyond calorie restriction

Researchers discovered that a healthy low-carb diet and time-restricted eating, combined with moderate calorie restriction, offer significant weight loss and gut health benefits for overweight

November 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.